Effect of matrine and carvedilol on collagen and MMPs activity of hypertrophy myocardium induced by pressure overload
- PMID: 16502514
- PMCID: PMC1419068
- DOI: 10.1631/jzus.2006.B0245
Effect of matrine and carvedilol on collagen and MMPs activity of hypertrophy myocardium induced by pressure overload
Abstract
Objective: To explore the effect and mechanism of matrine (Mt.) on myocardial interstitial fibrosis induced by pressure overload.
Methods: Pressure overloaded myocardial hypertrophy was produced by banding of aorta abdominalis in 67 male Sprague-Dawley rats weighing (200+/-15) g. The rats were assigned into one of the following groups: sham-operation control, operation control, operation group treated with matrine (15 mg/(kg.d)) and treated with carvedilol (Car.) (3.6 mg/(kg.d)) group. The rats were given drugs one day after operation. Five weeks after treatment, the left ventricular weight (LVW) was measured and the volume of myocardial cells was detected with Hematoxylin-Eosin (H-E) stain and Masson stain was used to assess the level of fibrosis of the myocardial matrix. Myocardial metalloproteinase activity was quantified with zymography, and survival rate was calculated.
Results: Survival rate significantly decreased (P<0.05), LVW/BW (body weight), MMP-2 (matrix metalloproteinase-2) activity (P<0.05), size of cardiomyocytes and interstitial fibrosis obviously increased in the operation group compared with sham control group. Mt. and Car. treatment can significantly increase survival rate (P<0.05), decrease LVW/BW (P<0.05) and MMP-2 activity (P<0.05), decrease size of cardiomyocytes and interstitial fibrosis compared with operation group. But there was difference compared with sham group.
Conclusion: Matrine was shown to be able to prevent cardiac remodelling of hypertrophy cardium induced by pressure overload including myocardial hypertrophy and fibrosis which may be associated with the decrease in MMP-2 activity of heart.
Figures











Similar articles
-
Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy.Hypertension. 2005 Nov;46(5):1213-8. doi: 10.1161/01.HYP.0000185689.65045.4c. Epub 2005 Oct 10. Hypertension. 2005. PMID: 16216989
-
Effect of captopril on the prevention and regression of myocardial cell hypertrophy and interstitial fibrosis in pressure overload cardiac hypertrophy.Am Heart J. 1992 Sep;124(3):700-9. doi: 10.1016/0002-8703(92)90281-y. Am Heart J. 1992. PMID: 1387507
-
Carvedilol prevents cardiac hypertrophy and overexpression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in pressure-overloaded rat heart.J Biomed Sci. 2005;12(2):409-20. doi: 10.1007/s11373-005-3008-x. J Biomed Sci. 2005. PMID: 15942707
-
Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension.Am J Cardiol. 1990 Apr 3;65(14):1G-7G. doi: 10.1016/0002-9149(90)90952-w. Am J Cardiol. 1990. PMID: 2138851 Review.
-
Myocardial collagen remodeling in pressure overload hypertrophy. A case for interstitial heart disease.Am J Hypertens. 1989 Dec;2(12 Pt 1):931-40. doi: 10.1093/ajh/2.12.931. Am J Hypertens. 1989. PMID: 2532916 Review.
Cited by
-
Matrine Is Identified as a Novel Macropinocytosis Inducer by a Network Target Approach.Front Pharmacol. 2018 Jan 26;9:10. doi: 10.3389/fphar.2018.00010. eCollection 2018. Front Pharmacol. 2018. PMID: 29434546 Free PMC article.
-
Matrine inhibits the migratory and invasive properties of nasopharyngeal carcinoma cells.Mol Med Rep. 2015 Jun;11(6):4158-64. doi: 10.3892/mmr.2015.3276. Epub 2015 Jan 29. Mol Med Rep. 2015. PMID: 25633440 Free PMC article.
-
Carvedilol improves biventricular fibrosis and function in experimental pulmonary hypertension.J Mol Med (Berl). 2015 Jun;93(6):663-74. doi: 10.1007/s00109-015-1251-9. Epub 2015 Jan 18. J Mol Med (Berl). 2015. PMID: 25595602
-
Matrine Inhibits the Wnt3a/β-Catenin Signalling to Attenuate Pressure Overload-Induced Atrial Remodelling and Vulnerability to Atrial Fibrillation.J Cell Mol Med. 2025 May;29(10):e70617. doi: 10.1111/jcmm.70617. J Cell Mol Med. 2025. PMID: 40407710 Free PMC article.
-
Congestive heart failure model representing aortic banding induced hypertrophy: A study to analyse extent of pressure overload and alteration in myocardial structure and function.Int J Cardiol Heart Vasc. 2021 Mar 22;34:100755. doi: 10.1016/j.ijcha.2021.100755. eCollection 2021 Jun. Int J Cardiol Heart Vasc. 2021. PMID: 33816767 Free PMC article.
References
-
- Ai J, Gao HH, He SZ, Wang L, Luo DL, Yang BF. The influence of intracellular [Ca2+]i of ventricular myocytes of guinea pig treated with matrine. Acta Harbin Medical College. 2000;34(4):235–236. (in Chinese)
-
- Cohn JN. Structural basis for heart failure ventricular remodeling and its pharmacological inhibition. Circulation. 1995;91:2504–2507. - PubMed
-
- Doering CW, Jalil JE, Janicki JS, Pick R, Aghili S, Abrahams C, Weber KT. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res. 1988;22:686–695. - PubMed
-
- Fung JW, Yu CM, Yip G, Chan S, Yandle TG, Richards AM, Nicholls MG, Sanderson JE. Effect of beta-blockade (carvedilol or metoprolol) on activation of the rennin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. Am J Cardiol. 2003;92(4):406–410. doi: 10.1016/S0002-9149(03)00658-1. - DOI - PubMed
-
- Hu YH, Ouyang JP, Li YQ, Yang HL, Xu Y. The influence of cardiac fibroblast cycles and neucleo antigen expression of proliferate cells. Acta Wuhan University: Medical Edition. 2004;3:224–227. (in Chinese)
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous